Survival of Hemodialysis Patients in the United States Is Improved With a Greater Quantity of Dialysis

American Journal of Kidney Diseases

Volumn 23, Issue 5, 1994, Pages 670-680

  Parker, Tom F ^a,b,c   Husni, Leigh ^a,b,c   Huang, Wei ^a,b,c   Lew, Nancy ^a,b,c   Lowrie, Edmund G ^a,b,c  

^a Dallas Nephrology Associates   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c National Medical Care Inc   (United States)

Author keywords

adequacy; clearance; HemodialysiS; Kt V; mortality; urea reduction ratio

Indexed keywords

ERYTHROPOIETIN; UREA;

ADULT; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PATIENT MONITORING; PROTEIN DEGRADATION; SURVIVAL RATE; UNITED STATES;

EID: 0028217157     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)70277-9     Document Type: Article

References (48)

1. Proceedings from the Morbidity, Mortality and Prescription of Dialysis Symposium: Dallas, TX, September 15–17, 1989
2. Adequacy of hemodialysis
3. Increasing dose of dialysis improves mortality and nutritional parameters in hemodialysis patients
4. Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients
5. Is insufficient dialysis a cause for high morbidity in diabetic patients?
6. The influence of urea kinetic modeling (UKM) on gross mortality in hemodialysis
7. Lower mortality and morbidity associated with higher Kt/V in hemodialysis patients
8. Survival as an index of adequacy of dialysis
9. Lower morbidity associated with higher Kt/V in stable hemodialysis patients
10. Analysis of time, nutrition, and Kt/V as risk factors for mortality in dialysis patients
11. Death risk in hemodialysis patients. The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
12. Mortality and the length of dialysis
13. Diabetic patients treated with a high Kt/V have a lower risk of death than standard KtjV
14. The dose of hemodialysis according to dialysis prescription in Europe and the United States
15. Shortfalls in the delivery of dialysis
16. USRDS: Hemodialysis prescription and delivery in the U.S.: Results from USRDS case mix study
17. Hemodialysis prescription and delivery in a metropolitan community
18. A kinetic survey of US hemodialysis prescriptions
19. Mortality and duration of hemodialysis treatment
20. The solute kinetics of intermittent dialysis therapy
21. Hemodialysis: Technique and kinetic considerations
22. Mathematical modeling of dialysis therapy
23. Control of dialysis by a single-pool model: The National Cooperative Dialysis Study
24. A mechanistic analysis of the National Dialysis Study
25. The urea reduction ratio (URR). A simple method for evaluating hemodialysis treatment
26. Statistical Methods in Cancer Research, vol II
27. Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates
28. Five year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987
29. Mortality in chronic dialysis patients in Japan
30. Dialysis treatment in Australia, 1982-1988
31. Results from the Canadian Renal Failure Registry
32. Results of renal replacement therapy in Europe, 1980 to 1987
33. Morbidity and mortality of United States dialysis patients—The legacy of inadequate nephrologist training?
34. Impact of reimbursement regulations on patient management
35. A re-appraisal of the National Cooperative Dialysis Study
36. Assessing the adequacy of dialysis
37. Adequacy of dialysis. A critical analysis
38. Optimizing survival in hemodialysis patients
39. urea, and Kt/V in achieving optimal dialysis. A critical reappraisal
40. Kt/V: Patients do not get what the physician prescribes
41. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis
42. A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients